Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix in the United Kingdom

NCT01905462 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01905462
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01905462 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-marketing Safety Study to Assess the Risk of Spontaneous Abortions in Women Exposed to Cervarix in the United Kingdom
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
November 30, 2012
Completion date
August 31, 2013
Enrollment
1,046 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infections, papillomavirus